BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 18067013)

  • 1. Thrombocytosis in myelodysplastic and myelodysplastic/myeloproliferative syndromes.
    Kodali D; Mesa H; Rawal A; Cao Q; Gupta P
    Leuk Lymphoma; 2007 Dec; 48(12):2375-80. PubMed ID: 18067013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A retrospective analysis of myelodysplastic syndromes with thrombocytosis: reclassification of the cases by WHO proposals.
    Cabello AI; Collado R; Ruiz MA; Martínez J; Navarro I; Ferrer R; Sosa AM; Carbonell F
    Leuk Res; 2005 Apr; 29(4):365-70. PubMed ID: 15725469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bortezomib is an effective agent for MDS/MPD syndrome with 5q- anomaly and thrombocytosis.
    Terpos E; Verrou E; Banti A; Kaloutsi V; Lazaridou A; Zervas K
    Leuk Res; 2007 Apr; 31(4):559-62. PubMed ID: 16820206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red Blood Cell Transfusion Dependency and Hyperferritinemia Are Associated with Impaired Survival in Patients Diagnosed with Myelodysplastic Syndromes: Results from the First Polish MDS-PALG Registry.
    Waszczuk-Gajda A; Mądry K; Machowicz R; Drozd-Sokołowska J; Stella-Hołowiecka B; Mital A; Obara A; Szmigielska-Kapłon A; Sikorska A; Subocz E; Jędrzejczak WW; Dwilewicz-Trojaczek J
    Adv Clin Exp Med; 2016; 25(4):633-41. PubMed ID: 27629836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Splenectomy in patients with mixed myelodysplastic/myeloproliferative disease.
    Kraemer D; Rüdiger T; Reimer P; Müller-Hermelink HK; Wilhelm M
    Ann Hematol; 2002 Jun; 81(6):308-11. PubMed ID: 12107559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Marked thrombocytosis in a child with advanced myelodysplastic syndrome.
    Claviez A; Ngoumou B; Harder L; Baumann I; Niemeyer C
    Leuk Lymphoma; 2004 Apr; 45(4):849-50. PubMed ID: 15160971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders.
    Hall J; Foucar K
    Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spontaneous remission of anemia associated with a myelodysplastic syndrome with disease evolution into a myeloproliferative state.
    Tefferi A; Inwards DJ; Hoyer JD
    Acta Haematol; 1999 Mar; 101(1):50-2. PubMed ID: 10085439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of NPM1-mutated AML with a history of myelodysplastic syndromes or myeloproliferative neoplasms.
    Schnittger S; Bacher U; Haferlach C; Alpermann T; Dicker F; Sundermann J; Kern W; Haferlach T
    Leukemia; 2011 Apr; 25(4):615-21. PubMed ID: 21233837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Mixed myelodysplastic and myeloproliferative syndromes].
    Neuwirtová R; Mociková K; Jelínek J; Musilová J; Havlícek F; Adamkov M; Michalová K; Cermák J; Jonásová A; Smolíková A; Straub J; Tothová E; Voglová J; Vozobulová V; Waltrová L
    Cas Lek Cesk; 1997 Dec; 136(23):724-9. PubMed ID: 9476375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two new classifications for pediatric myelodysplastic and myeloproliferative disorders.
    Occhipinti E; Correa H; Yu L; Craver R
    Pediatr Blood Cancer; 2005 Mar; 44(3):240-4. PubMed ID: 15368549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sideroblastic anaemia with reactive thrombocytosis versus myelodysplastic/myeloproliferative disease.
    Pérez Sánchez I; Pérez Corrala A; Menarguez Palanca J; Mayayo Crespo M; Escudero Soto A; Pintado Cros T
    Leuk Lymphoma; 2003 Mar; 44(3):557-9. PubMed ID: 12688334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of Acute Myeloid Leukemia Progression on the Prognosis of 831 Patients With Myelodysplastic Syndromes From the Argentine Database.
    Enrico A; Bestach Y; Flores MG; Arbelbide J; Serale C; Novoa V; Crisp R; Rivas MM; Larripa I; Belli C
    Clin Lymphoma Myeloma Leuk; 2017 Nov; 17(11):743-752.e5. PubMed ID: 28797621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G-CSF priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm.
    Becker PS; Medeiros BC; Stein AS; Othus M; Appelbaum FR; Forman SJ; Scott BL; Hendrie PC; Gardner KM; Pagel JM; Walter RB; Parks C; Wood BL; Abkowitz JL; Estey EH
    Am J Hematol; 2015 Apr; 90(4):295-300. PubMed ID: 25545153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparameter flow cytometry reveals myelodysplasia-related aberrant antigen expression in myelodysplastic/myeloproliferative neoplasms.
    Kern W; Bacher U; Schnittger S; Alpermann T; Haferlach C; Haferlach T
    Cytometry B Clin Cytom; 2013 May; 84(3):194-7. PubMed ID: 23283847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience.
    Maung SW; Burke C; Hayde J; Walshe J; McDermott R; Desmond R; McHugh J; Enright H
    Hematology; 2017 Jul; 22(6):341-346. PubMed ID: 28196450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England.
    Phekoo KJ; Richards MA; Møller H; Schey SA;
    Haematologica; 2006 Oct; 91(10):1400-4. PubMed ID: 17018393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High frequency of the JAK2 V617F mutation in patients with thrombocytosis (platelet count>600x109/L) and ringed sideroblasts more than 15% considered as MDS/MPD, unclassifiable.
    Gattermann N; Billiet J; Kronenwett R; Zipperer E; Germing U; Nollet F; Criel A; Selleslag D
    Blood; 2007 Feb; 109(3):1334-5. PubMed ID: 17244688
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders.
    Steensma DP; Porcher JC; Hanson CA; Lathrop CL; Hoyer JD; Lasho TA; Tefferi A; Higgs DR
    Br J Haematol; 2007 Nov; 139(3):439-42. PubMed ID: 17910635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.